Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys

Transplantation

Volumn 73, Issue 6, 2002, Pages 874-880

  Jonker, Margreet ^a   Ringers, Jan ^a   Ossevoort, Miriam A ^a   Slingerland, Wim ^a   Van den Hout, Yvon ^a   Haanstra, Krista ^a   Wubben, Jacqueline ^a   Kuhn, Eva ^a   Friend, Peter ^a   Calne, Roy ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; IMMUNOTOXIN; MONOCLONAL ANTIBODY CD3; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE;

EID: 0037181437     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200203270-00008     Document Type: Article

References (27)

1. Cell migration, chimerism, and graft acceptance
2. Mixed chimerism as an approach to transplantation tolerance
3. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: Absence of chronic allograft nephropathy
4. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts
5. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
6. Prope tolerance: A step in the search for tolerance in the clinic
7. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients
8. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients
9. Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates
10. Unprecedented polymorphism of Mhc-DRB region configurations in rhesus macaques
11. Characterization of the ABO blood group genes in macaques: Evidence for convergent evolution
12. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9
13. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway
14. The technique of kidney transplantation in rhesus monkeys
15. The Banff 97 working classification of renal allograft pathology
16. Side effects and immunogenicity of murine lymphocyte-specific monoclonal antibodies in subhuman primates
17. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation
18. Complete withdrawal of immunosuppression in kidney allograft recipients: A prospective study in rhesus monkeys
19. Complete withdrawal of immunosuppression in allograft recipients. A study in rhesus monkeys
20. Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression
21. Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: Risk factors, incidence, progression, and management
22. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus
23. Sirolimus and cyclosporin for renal transplantation
24. Coadministration of Neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: Potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment
25. Correlation between pretransplantation test dose cyclosporine pharmacokinetic profiles and posttransplantation sirolimus blood levels in renal transplant recipients
26. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation
27. Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: Interaction with cyclosporine